Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Transitioning to whole-body SPECT/CT in prostate cancer staging: a new concept for a better imaging workflow.

Weissinger M, Kupferschläger J, La Fougère C, Dittmann H, Fiz F.

Nuklearmedizin. 2019 Dec;58(6):451-459. doi: 10.1055/a-1022-4115. Epub 2019 Nov 11.

PMID:
31711243
2.

Automated Definition of Skeletal Disease Burden in Metastatic Prostate Carcinoma: A 3D Analysis of SPECT/CT Images.

Fiz F, Dittmann H, Campi C, Weissinger M, Sahbai S, Reimold M, Stenzl A, Piana M, Sambuceti G, la Fougère C.

Cancers (Basel). 2019 Jun 21;11(6). pii: E869. doi: 10.3390/cancers11060869.

3.

Tumor Burden and Intraosseous Metabolic Activity as Predictors of Bone Marrow Failure during Radioisotope Therapy in Metastasized Prostate Cancer Patients.

Fiz F, Sahbai S, Campi C, Weissinger M, Dittmann H, Marini C, Piana M, Sambuceti G, la Fougère C.

Biomed Res Int. 2017;2017:3905216. doi: 10.1155/2017/3905216. Epub 2017 Dec 25.

4.

A Prospective Study of Quantitative SPECT/CT for Evaluation of Lung Shunt Fraction Before SIRT of Liver Tumors.

Dittmann H, Kopp D, Kupferschlaeger J, Feil D, Groezinger G, Syha R, Weissinger M, la Fougère C.

J Nucl Med. 2018 Sep;59(9):1366-1372. doi: 10.2967/jnumed.117.205203. Epub 2018 Jan 25.

5.

Sentinel lymph node mapping using SPECT/CT and gamma probe in endometrial cancer: an analysis of parameters affecting detection rate.

Sahbai S, Taran FA, Staebler A, Wallwiener D, la Fougère C, Brucker S, Dittmann H.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1511-1519. doi: 10.1007/s00259-017-3692-6. Epub 2017 Apr 3.

PMID:
28374119
6.
7.

Pericervical Injection of 99mTc-Nanocolloid Is Superior to Peritumoral Injection for Sentinel Lymph Node Detection of Endometrial Cancer in SPECT/CT.

Sahbai S, Taran FA, Fiz F, Staebler A, Becker S, Solomayer E, Wallwiener D, la Fougère C, Brucker S, Dittmann H.

Clin Nucl Med. 2016 Dec;41(12):927-932.

PMID:
27749429
8.

Assessment of the parenchymal blood volume by C-arm computed tomography for radioembolization dosimetry.

Grözinger G, Kupferschläger J, Dittmann H, Maurer M, Grosse U, la Fougère C, Nikolaou K, Syha R, Ketelsen D.

Eur J Radiol. 2016 Sep;85(9):1525-31. doi: 10.1016/j.ejrad.2016.06.005. Epub 2016 Jun 7.

PMID:
27501884
9.

Improved selectivity of mIBG uptake into neuroblastoma cells in vitro and in vivo by inhibition of organic cation transporter 3 uptake using clinically approved corticosteroids.

Bayer M, Schmitt J, Dittmann H, Handgretinger R, Bruchelt G, Sauter AW.

Nucl Med Biol. 2016 Sep;43(9):543-551. doi: 10.1016/j.nucmedbio.2016.05.013. Epub 2016 May 27.

PMID:
27376201
10.

Hypothyroidism during second-line treatment of multidrug-resistant tuberculosis: a prospective study.

Bares R, Khalid N, Daniel H, Dittmann H, Reimold M, Gallwitz B, Schmotzer C.

Int J Tuberc Lung Dis. 2016 Jul;20(7):876-81. doi: 10.5588/ijtld.15.0692.

PMID:
27287638
11.

11C-methionine PET/CT after inconclusive 99mTc-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism.

Braeuning U, Pfannenberg C, Gallwitz B, Teichmann R, Mueller M, Dittmann H, Reimold M, Bares R.

Nuklearmedizin. 2015;54(1):26-30. doi: 10.3413/Nukmed-0686-14-07. Epub 2014 Nov 27.

PMID:
25427653
12.

Peptide receptor radionuclide therapy of neuroendocrine tumors with (90)Y-DOTATOC: is treatment response predictable by pre-therapeutic uptake of (68)Ga-DOTATOC?

Öksüz MÖ, Winter L, Pfannenberg C, Reischl G, Müssig K, Bares R, Dittmann H.

Diagn Interv Imaging. 2014 Mar;95(3):289-300. doi: 10.1016/j.diii.2013.07.006. Epub 2013 Sep 12.

13.

Dose-escalated radioimmunotherapy as part of reduced intensity conditioning for allogeneic transplantation in patients with advanced high-grade non-Hodgkin lymphoma.

Bethge WA, von Harsdorf S, Bornhauser M, Federmann B, Stelljes M, Trenschel R, Baurmann H, Dittmann H, Faul C, Vogel W, Kanz L, Bunjes D.

Bone Marrow Transplant. 2012 Nov;47(11):1397-402. doi: 10.1038/bmt.2012.62. Epub 2012 Apr 16.

PMID:
22504934
14.

[Allogeneic stem cell transplantation for acute myeloid leukemia and HIV infection--case 3/2012].

Schneidawind D, Dorn C, Faul C, Vogel W, Berg C, Beck R, Korn K, Dittmann H, Schleicher J, Erbersdobler A, Jahn G, Kanz L, Bethge W.

Dtsch Med Wochenschr. 2012 Mar;137(10):495. doi: 10.1055/s-0031-1299022. Epub 2012 Feb 28. German.

PMID:
22374660
15.

Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomas.

Müssig K, Wehrmann T, Dittmann H, Wehrmann M, Ueberberg B, Schulz S, Bares R, Petersenn S.

Clin Endocrinol (Oxf). 2012 Jul;77(1):139-45. doi: 10.1111/j.1365-2265.2012.04343.x.

PMID:
22248072
16.

[Multimodal imaging in Pheochromocytoma].

Müssig K, Dittmann H, Dudziak K, Horger M.

Rofo. 2011 Nov;183(11):995-1000. German. No abstract available.

PMID:
22232796
17.

[A rare differential diagnosis of primary hyperparathyreoidism - case 12/2011].

Sauer-Schulz A, Schnauder G, Dittmann H, Müssig K.

Dtsch Med Wochenschr. 2011 Dec;136(50):2621. doi: 10.1055/s-0031-1292848. Epub 2011 Dec 7. German.

PMID:
22160955
18.

Follow-up of acute osteomyelitis in children: the possible role of PET/CT in selected cases.

Warmann SW, Dittmann H, Seitz G, Bares R, Fuchs J, Schäfer JF.

J Pediatr Surg. 2011 Aug;46(8):1550-6. doi: 10.1016/j.jpedsurg.2010.11.037.

PMID:
21843723
19.

A dual-inhibition study on vascular smooth muscle cells with meclofenamic acid and β-irradiation for the prevention of restenosis.

Sauter A, Landers A, Dittmann H, Pritzkow M, Wiesinger B, Bayer M, Bantleon R, Schmehl J, Claussen CD, Kehlbach R.

J Vasc Interv Radiol. 2011 May;22(5):623-9. doi: 10.1016/j.jvir.2010.12.015. Epub 2011 Mar 17.

PMID:
21414804
20.

Accuracy of parathyroid imaging: a comparison of planar scintigraphy, SPECT, SPECT-CT, and C-11 methionine PET for the detection of parathyroid adenomas and glandular hyperplasia.

Oksüz MO, Dittmann H, Wicke C, Müssig K, Bares R, Pfannenberg C, Eschmann SM.

Diagn Interv Radiol. 2011 Dec;17(4):297-307. doi: 10.4261/1305-3825.DIR.3486-10.1. Epub 2011 Feb 8.

21.

In vitro comparison of the antiproliferative effects of rhenium-186 and rhenium-188 on human aortic endothelial cells.

Sauter A, Arthasana D, Dittmann H, Pritzkow M, Wiesinger B, Schmehl J, Brechtel K, Bantleon R, Claussen C, Kehlbach R.

Cardiovasc Intervent Radiol. 2011 Aug;34(4):816-23. doi: 10.1007/s00270-010-0003-z. Epub 2010 Nov 3.

PMID:
21046387
22.

Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study.

Bethge WA, Lange T, Meisner C, von Harsdorf S, Bornhaeuser M, Federmann B, Stadler M, Uharek L, Stelljes M, Knop S, Wulf G, Trenschel R, Vucinic V, Dittmann H, Faul C, Vogel W, Kanz L, Bunjes D.

Blood. 2010 Sep 9;116(10):1795-802. doi: 10.1182/blood-2010-02-270538. Epub 2010 Jun 7.

PMID:
20530284
23.

PET/CT with 18F-FLT: does it improve the therapeutic management of metastatic germ cell tumors?

Pfannenberg C, Aschoff P, Dittmann H, Mayer F, Reischl G, von Weyhern C, Kanz L, Claussen CD, Bares R, Hartmann JT.

J Nucl Med. 2010 Jun;51(6):845-53. doi: 10.2967/jnumed.109.070425. Epub 2010 May 19.

24.

Simultaneous evaluation of renal morphology and function in live kidney donors using dynamic magnetic resonance imaging.

Artunc F, Yildiz S, Rossi C, Boss A, Dittmann H, Schlemmer HP, Risler T, Heyne N.

Nephrol Dial Transplant. 2010 Jun;25(6):1986-91. doi: 10.1093/ndt/gfp772. Epub 2010 Jan 25.

PMID:
20100730
25.

PET/CT for the assessment and quantification of (90)Y biodistribution after selective internal radiotherapy (SIRT) of liver metastases.

Werner MK, Brechtel K, Beyer T, Dittmann H, Pfannenberg C, Kupferschläger J.

Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):407-8. doi: 10.1007/s00259-009-1317-4. Epub 2009 Dec 9. No abstract available.

PMID:
19997914
26.

Comprehensive assessment of renal function and vessel morphology in potential living kidney donors: an MRI-based approach.

Rossi C, Boss A, Artunc F, Yildiz S, Martirosian P, Dittmann H, Claussen CD, Heyne N, Schick F, Schlemmer HP.

Invest Radiol. 2009 Nov;44(11):705-11. doi: 10.1097/RLI.0b013e3181b35a70.

PMID:
19809340
27.

Pyeloplasty in children: is there a difference in patients with or without crossing lower pole vessel?

Hacker HW, Szavay P, Dittmann H, Haber HP, Fuchs J.

Pediatr Surg Int. 2009 Jul;25(7):607-11. doi: 10.1007/s00383-009-2385-z. Epub 2009 Jun 6.

PMID:
19504112
28.

Uptake of mIBG and catecholamines in noradrenaline- and organic cation transporter-expressing cells: potential use of corticosterone for a preferred uptake in neuroblastoma- and pheochromocytoma cells.

Bayer M, Kuçi Z, Schömig E, Gründemann D, Dittmann H, Handgretinger R, Bruchelt G.

Nucl Med Biol. 2009 Apr;36(3):287-94. doi: 10.1016/j.nucmedbio.2008.12.010.

PMID:
19324274
29.

3'-Deoxy-3'-[(18)F]fluorothymidine (FLT) uptake in breast cancer cells as a measure of proliferation after doxorubicin and docetaxel treatment.

Dittmann H, Jusufoska A, Dohmen BM, Smyczek-Gargya B, Fersis N, Pritzkow M, Kehlbach R, Vonthein R, Machulla HJ, Bares R.

Nucl Med Biol. 2009 Feb;36(2):163-9. doi: 10.1016/j.nucmedbio.2008.10.012.

PMID:
19217528
30.

Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer.

Eschmann SM, Friedel G, Paulsen F, Reimold M, Hehr T, Budach W, Dittmann H, Langen HJ, Bares R.

Lung Cancer. 2007 Feb;55(2):165-71. Epub 2006 Nov 28.

PMID:
17129635
31.

Influence of short-term interruption of antithyroid drugs on the outcome of radioiodine therapy of Graves' disease: results of a prospective study.

Eschmann SM, Thelen MH, Dittmann H, Bares R.

Exp Clin Endocrinol Diabetes. 2006 May;114(5):222-6.

PMID:
16804795
32.

[Clinical pathways in endocrinology and diabetology].

Gallwitz B, Lehnert H, Dittmann H, Honegger J, Teichmann R, Tatagiba M, Häring HU.

Internist (Berl). 2006 Jul;47(7):707-10, 711-2. Review. German.

PMID:
16733715
33.

Early effects of rhenium-188 treatment on proliferation, migration, and matrix synthesis of cultured human aortic smooth muscle cells.

Kehlbach R, Dittmann H, Schmid T, Khorchidi S, Bantleon R, Rodemann HP, Claussen CD, Duda SH, Wiskirchen J.

Strahlenther Onkol. 2006 Mar;182(3):164-71.

PMID:
16520911
34.

Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?

Eschmann SM, Friedel G, Paulsen F, Reimold M, Hehr T, Budach W, Scheiderbauer J, Machulla HJ, Dittmann H, Vonthein R, Bares R.

Eur J Nucl Med Mol Imaging. 2006 Mar;33(3):263-9. Epub 2005 Nov 4. Erratum in: Eur J Nucl Med Mol Imaging. 2006 Mar;33(3):389.

PMID:
16270214
35.
36.

Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.

Eschmann SM, Paulsen F, Reimold M, Dittmann H, Welz S, Reischl G, Machulla HJ, Bares R.

J Nucl Med. 2005 Feb;46(2):253-60.

37.

The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancer.

Eschmann SM, Bitzer M, Paulsen F, Friedel G, Besenfelder H, Horger M, Reimold M, Dittmann H, Pfannenberg AC, Bares R.

Nucl Med Commun. 2004 Sep;25(9):909-15.

PMID:
15319596
38.

[Dose dependent effects of the combined beta-gamma-emitter 188Rhenium on the growth of human vessel wall cells].

Henning E, Dittmann H, Wiskirchen J, Bantleon R, Kehlbach R, Claussen CD, Duda SH.

Rofo. 2004 Mar;176(3):404-8. German.

PMID:
15026955
39.

PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot study.

Smyczek-Gargya B, Fersis N, Dittmann H, Vogel U, Reischl G, Machulla HJ, Wallwiener D, Bares R, Dohmen BM.

Eur J Nucl Med Mol Imaging. 2004 May;31(5):720-4. Epub 2004 Feb 19.

PMID:
14991243
40.

[18F]FLT PET for diagnosis and staging of thoracic tumours.

Dittmann H, Dohmen BM, Paulsen F, Eichhorn K, Eschmann SM, Horger M, Wehrmann M, Machulla HJ, Bares R.

Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1407-12. Epub 2003 Jul 26.

PMID:
12898201
41.

Early changes in [18F]FLT uptake after chemotherapy: an experimental study.

Dittmann H, Dohmen BM, Kehlbach R, Bartusek G, Pritzkow M, Sarbia M, Bares R.

Eur J Nucl Med Mol Imaging. 2002 Nov;29(11):1462-9. Epub 2002 Sep 6.

PMID:
12397465
43.

Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphoma.

Dittmann H, Sokler M, Kollmannsberger C, Dohmen BM, Baumann C, Kopp A, Bares R, Claussen CD, Kanz L, Bokemeyer C.

Oncol Rep. 2001 Nov-Dec;8(6):1393-9.

PMID:
11605073
44.

[Dose-dependent effects of the combined beta/gamma emitter 186-Rhenium on the growth of human vessel wall cells].

Wiskirchen J, Dittmann H, Gebert R, Burgbacher B, Betsch A, Schöber W, Johst U, Dohmen BM, Kehlbach R, Rodemann HP, Bares R, Duda SH.

Rofo. 2001 Jan;173(1):72-6. German.

PMID:
11225421
45.

Rhenium-188 for inhibition of human aortic smooth muscle cell proliferation.

Wiskirchen J, Dittmann H, Kehlbach R, Vogel-Claussen J, Gebert R, Dohmen BM, Schöber W, Bares R, Rodemann HP, Claussen CD, Duda SH.

Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):809-15.

PMID:
11172964
46.

Synthesis and silica-based immobilization of monofunctionalized cyclomaltoheptaose derivatives for enantioselective HPLC.

Dittmann H, Scharwächter K, König WA.

Carbohydr Res. 2000 Feb 11;324(2):75-96.

PMID:
10702875
47.

[Improved assessment of the left ventricular endocardial border by intravenous injection of a left heart contrast agent].

Dittmann H, Razwan E, Greis C, Seipel L.

Ultraschall Med. 1999 Oct;20(5):185-90. German.

PMID:
10595386
49.

In vitro studies on the cellular uptake of melanoma imaging aminoalkyl-iodobenzamide derivatives (ABA).

Dittmann H, Coenen HH, Zölzer F, Dutschka K, Brandau W, Streffer C.

Nucl Med Biol. 1999 Jan;26(1):51-6.

PMID:
10096501
50.

Friedreich's ataxia with retained tendon reflexes: molecular genetics, clinical neurophysiology, and magnetic resonance imaging.

Klockgether T, Zühlke C, Schulz JB, Bürk K, Fetter M, Dittmann H, Skalej M, Dichgans J.

Neurology. 1996 Jan;46(1):118-21.

PMID:
8559357

Supplemental Content

Loading ...
Support Center